Dr Reddy’s launches oral semaglutide tablet Obeda for diabetes patients in India

Dr Reddy’s launches oral semaglutide tablet Obeda for diabetes patients in India

Dr. Reddy's Laboratories on Tuesday announced the launch of its oral semaglutide biosimilar tablet, branded as Obeda®, for the treatment of type 2 diabetes mellitus in India. The Hyderabad-based pharmaceutical major said the launch strengthens its position in the growing GLP-1 therapies segment fol...

Travel

Save money on your next trip with these 7 cheap shopping cities

Save money on your next trip with these 7 cheap shopping cities

The whole experience of shopping elsewhere is thrilling. With so many global brands at your fingertips, it's difficult to resist the temptation to shop. Even though the price tag is alluring, many of us tend to be hesitant. The cost of shopping over...